Hiromichi Kodaira

Title: Hiromichi Kodaira: Innovator in Pharmaceutical Formulations

Introduction

Hiromichi Kodaira is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in drug formulation. With a total of two patents to his name, his work focuses on innovative solutions for medical challenges.

Latest Patents

Kodaira's latest patents include a transdermal absorptive drug formulation. This formulation contains 3-isobutyryl-2-isopropylpyrazolo [1,5-a]pyridine as the active ingredient, which is effective for treating bronchial asthma and cerebrovascular disorders. The formulation is designed to provide excellent sustained release and long-acting characteristics while substantially reducing side effects such as nausea and vomiting. Another significant patent is for freeze-dried pharmaceutical preparations for parenteral use. These preparations contain antibacterial quinolinecarboxylic acid derivatives and are characterized by their stability against light and heat, along with rapid solubility.

Career Highlights

Kodaira is associated with Kyorin Seiyaku Kabushiki Kaisha, a company known for its commitment to pharmaceutical innovation. His work has contributed to advancements in drug delivery systems and therapeutic efficacy.

Collaborations

Some of his notable coworkers include Shinji Kamijo and Jun Imai, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Hiromichi Kodaira's contributions to pharmaceutical formulations demonstrate his commitment to improving medical treatments through innovation. His patents reflect a dedication to enhancing patient care and addressing critical health issues.